COMMUNIQUÉS West-GlobeNewswire

-
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
27/08/2025 -
Cytokinetics to Participate in September Investor Conferences
27/08/2025 -
KFSHRC’s 24/7 Emergency Virtual Clinic Serves Over 23,500 Patients in First Year
27/08/2025 -
Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure
27/08/2025 -
Quest PharmaTech Announces Results from AGM
27/08/2025 -
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
27/08/2025 -
Ipsen - July 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
27/08/2025 -
Ipsen - Juillet 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
27/08/2025 -
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand
27/08/2025 -
Ramsay Sante : Provisional annual Results at the end of June 2025
27/08/2025 -
RAMSAY SANTE : résultats annuels provisoires à fin juin 2025
27/08/2025 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
27/08/2025 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
27/08/2025 -
BioNTX Announces BIO CEO John Crowley as Featured Speaker at iC³® Life Science & Healthcare Innovation Summit
27/08/2025 -
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
27/08/2025 -
MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans
27/08/2025 -
Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound
27/08/2025 -
InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference
27/08/2025 -
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
27/08/2025
Pages